Widespread rescue missions for survivors have continued after devastating earthquakes rocked Venezuela.
READ MORENATO fighters were scrambled over Lithuania today after a kamikaze drone was feared to have entered its airspace.
It's a banger of a half-time meal.
REDWOOD CITY,Calif.,Oct. 16,2024-- MinIO,the world\'s leading high-performance object store,announced today a joint collaboration with Intel to bring its Enterprise Object Store to the Intel® Tib
BORTALA,China,Oct. 16,2024--In the beautiful Ebi Lake wetland,the State Grid Bortala Power Supply Company is infusing new vitality into this ecological treasure in a warm-hearted manner. In mid-Octobe
SINGAPORE,Oct. 17,2024--The renowned fashion brand URBAN REVIVO (UR) has officially unveiled its much-anticipated 2024 Fall/Winter collection,URBAN THINKING. To celebrate the launch,UR teamed up with
ADELAIDE,Australia,Oct. 17,2024-- Astec,a global manufacturer of medical equipment for assisted reproduction,has acquired Presagen\'s fertility product Life Whisperer,a non-invasive and rapid embryo a
LOUISVILLE,Ky.,Oct. 17,2024-- URSROBOT,a leader in AI-driven robotics,is excited to announce the upcoming release of the NEXMOW M2,an innovative commercial landscaping solution,at Equip EXPO 2024. Thi
SINGAPORE,Oct. 17,2024-- Digital travel platform Agoda has identified five Asian destinations ideal for remote work trips. The locations offer a mix of urban excitement,natural beauty,and in some cas
OPTIMIZED FOR SUPERIOR PERFORMANCE WITH INTEL 15TH GEN CORE ULTRA PROCESSORS AND Z890 PLATFORM HONG KONG,Oct. 17,2024-- KLEVV,the leading consumer memory and storage brand introduced by Essencore,toda
TOKYO,Oct. 17,2024-- Taiwan\'s AI infrastructure solutions leader,INFINITIX,has officially launched its Japanese subsidiary,INFINITIX Japan,to expand its presence in Japan\'s AI market. This move aims
The company aims at accelerating development of ready to launch satellite platforms for Global Space Missions
SHANGHAI,Oct. 14,2024--BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentat
© OfficialAffairs
